» Articles » PMID: 36481407

New Light on Treatment of Cervical Cancer: Chinese Medicine Monomers Can Be Effective for Cervical Cancer by Inhibiting the PI3K/Akt Signaling Pathway

Overview
Date 2022 Dec 8
PMID 36481407
Authors
Affiliations
Soon will be listed here.
Abstract

Cervical cancer (CC), as the most common malignant tumor of the female reproductive system, is infamous for its high morbidity and mortality rates. Its development and metastasis are intricate because numerous signaling pathways are involved. Since the cancer and the PI3K/Akt signaling pathway are closely intertwined, direct inhibition of either the PI3K/Akt pathway or its target genes and molecules may be remarkably constructive for treatment. Albeit remarkable advances in the treatment of CC, existing common anti-cancer medications are not without problems. These problems include myelotoxicity, cardiotoxicity, genotoxicity, and vasospasm, which are the most common and well-recognized toxicities associated with these medications. Therefore, it is necessary and urgent to develop novel, potent, secure, and more reasonably priced anticancer medications that are void of the above problems. Against this backdrop, Chinese medicine monomers have received more attention in recent years owing to their safety, low toxicity, few side effects, and anti-tumor properties. By regulating the PI3K/Akt signaling pathway, Chinese medicine monomers are effective not only in inhibiting CC growth, proliferation, apoptosis, invasion, migration, and reversing drug resistance but also in a variety of targets. Most previous earlier studies focused on the use of a single traditional Chinese medicine monomer to treat CC by regulating the PI3K/Akt signaling pathway rather than a combination of several such monomers. More importantly, to our knowledge, there has hardly been any study providing an exhaustive and comprehensive review of all the Chinese medicine monomers at CC. In response to this scarcity, we attempt in this paper to provide a comprehensive review of all the literature to date on traditional Chinese medicine monomers at cervical cancer, highlight the mechanisms and future prospects for their use in the prevention and treatment of cervical cancer.

Citing Articles

A specific super-enhancer actuated by berberine regulates EGFR-mediated RAS-RAF1-MEK1/2-ERK1/2 pathway to induce nasopharyngeal carcinoma autophagy.

Wu Y, Jia Q, Tang Q, Chen L, Deng H, He Y Cell Mol Biol Lett. 2024; 29(1):92.

PMID: 38943090 PMC: 11214260. DOI: 10.1186/s11658-024-00607-4.


Function of Long Noncoding RNAs in Glioma Progression and Treatment Based on the Wnt/β-Catenin and PI3K/AKT Signaling Pathways.

Li H, Liu J, Qin X, Sun J, Liu Y, Jin F Cell Mol Neurobiol. 2023; 43(8):3929-3942.

PMID: 37747595 PMC: 11407728. DOI: 10.1007/s10571-023-01414-9.


A Systematic Study of Anti-Osteosarcoma Mechanism of pH-Sensitive Charge-Conversion Cinnamaldehyde Polymeric Prodrug Micelles In Vitro.

Deng J, Wang Q, Xu H, Li G, Liu S, Chen Y Biomedicines. 2023; 11(6).

PMID: 37371619 PMC: 10295571. DOI: 10.3390/biomedicines11061524.